Retour
Fourchette du Jour
189,38 €
193,75 €
Fourchette 52 Semaines
171,00 €
242,80 €
Volume
2 392 160
Moyenne 50J / 200J
214,85 €
/
210,29 €
Clôture Précédente
189,35 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (626 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | 37,2 | 0,4 |
| P/B | 2,6 | 2,9 |
| ROE % | 7,1 | 3,8 |
| Net Margin % | 14,7 | 3,9 |
| Rev Growth 5Y % | -4,4 | 10,0 |
| D/E | 0,4 | 0,2 |
Insider Trading Activity
Buy ratio (90d)
0.0%
20 transactions
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 1, 2026 |
McGrew Matthew
Executive Vice President
|
grant | 21 974 | — | — |
| Feb 24, 2026 |
Milosevich Gregory M
Executive Vice President
|
other | 189 | 209,19 € | 39 537 € |
| Feb 24, 2026 |
Gutierrez-Ramos Jose-Carlos
SVP, Chief Science Officer
|
other | 344 | 209,19 € | 71 961 € |
| Feb 24, 2026 |
Bouda Christopher
VP, Chief Accounting Officer
|
other | 235 | 209,19 € | 49 160 € |
| Feb 24, 2026 |
Sawyer Montgomery Julie A
Executive Vice President
|
other | 372 | 209,19 € | 77 819 € |
| Feb 24, 2026 |
Couchara Georgeann
SVP, Human Resources
|
other | 101 | 209,19 € | 21 128 € |
| Feb 24, 2026 |
Riley Christopher Paul
Executive Vice President
|
other | 242 | 209,19 € | 50 624 € |
| Feb 19, 2026 |
Milosevich Gregory M
Executive Vice President
|
other | 2 640 | 58,59 € | — |
| Feb 19, 2026 |
Milosevich Gregory M
Executive Vice President
|
sell | 1 320 | 208,01 € | 274 575 € |
| Feb 4, 2026 |
Blair Rainer
President & CEO
|
grant | 8 474 | — | — |
| Jan 30, 2026 |
List Teri
Director
|
grant | 11 | 218,89 € | 2 408 € |
| Jan 30, 2026 |
Sanders A Shane
Director
|
grant | 184 | 218,89 € | 40 276 € |
| Nov 15, 2025 |
GRAY R BRADLEY
SVP Strategic Development
|
other | 1 402 | 221,21 € | 310 136 € |
| Nov 10, 2025 |
Couchara Georgeann
SVP, Human Resources
|
other | 8 352 | 88,24 € | — |
| Nov 10, 2025 |
Couchara Georgeann
SVP, Human Resources
|
sell | 5 174 | 210,44 € | 1 088 704 € |
| Jul 15, 2025 |
Zerhouni Elias A.
Director
|
other | 9 065 | 59,34 € | — |
| Jul 2, 2025 |
List Teri
Director
|
other | 9 006 | 59,34 € | — |
| May 15, 2025 |
Blair Rainer
President & CEO
|
other | 27 490 | — | — |
| May 15, 2025 |
Couchara Georgeann
SVP, Human Resources
|
other | 281 | 190,95 € | 53 657 € |
| May 15, 2025 |
Zerhouni Elias A.
Director
|
grant | 2 055 | — | — |
Points Clés
Revenue declined -4,43% annually over 5 years
Debt/Equity of 0,35 — conservative balance sheet
Generating 5,26B in free cash flow
P/E of 37,18 — premium valuation
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 7,33%
Cash machine — converts 145,55% of earnings into free cash flow
Croissance
Revenue Growth (5Y)
-4,43%
Revenue (1Y)2,90%
Earnings (1Y)-7,31%
FCF Growth (3Y)-4,61%
Qualité
Return on Equity
7,08%
ROIC5,43%
Net Margin14,71%
Op. Margin20,91%
Sécurité
Debt / Equity
0,35
Current Ratio1,87
Interest Coverage19,38
Valorisation
P/E Ratio
37,18
P/B Ratio2,56
EV/EBITDA28,84
Dividend Yield0,01%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 2,90% | Revenue Growth (3Y) | 1,41% |
| Earnings Growth (1Y) | -7,31% | Earnings Growth (3Y) | -12,90% |
| Revenue Growth (5Y) | -4,43% | Earnings Growth (5Y) | -13,42% |
| Profitability | |||
| Revenue (TTM) | 24,57B | Net Income (TTM) | 3,61B |
| ROE | 7,08% | ROA | 4,33% |
| Gross Margin | 60,93% | Operating Margin | 20,91% |
| Net Margin | 14,71% | Free Cash Flow (TTM) | 5,26B |
| ROIC | 5,43% | FCF Growth (3Y) | -4,61% |
| Safety | |||
| Debt / Equity | 0,35 | Current Ratio | 1,87 |
| Interest Coverage | 19,38 | Dividend Yield | 0,01% |
| Valuation | |||
| P/E Ratio | 37,18 | P/B Ratio | 2,56 |
| P/S Ratio | 5,47 | PEG Ratio | -9,18 |
| EV/EBITDA | 28,84 | Dividend Yield | 0,01% |
| Market Cap | 134,36B | Enterprise Value | 148,16B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 24,57B | 23,88B | 23,89B | 26,64B | 29,45B |
| Net Income | 3,61B | 3,90B | 4,76B | 7,21B | 6,43B |
| EPS (Diluted) | 5,04 | 5,29 | 6,38 | 9,64 | 8,61 |
| Gross Profit | 14,97B | 14,21B | 14,03B | 16,19B | 17,95B |
| Operating Income | 5,14B | 5,18B | 5,28B | 7,54B | 8,05B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 83,46B | 77,54B | 84,49B | 84,35B | 83,18B |
| Total Liabilities | 30,93B | 27,99B | 31,00B | 34,26B | 38,01B |
| Shareholders' Equity | 52,53B | 49,54B | 53,49B | 50,08B | 45,17B |
| Total Debt | 18,42B | 17,15B | 19,54B | 20,62B | 23,27B |
| Cash & Equivalents | 4,62B | 2,08B | 5,86B | 6,00B | 2,59B |
| Current Assets | 12,76B | 9,50B | 13,94B | 15,88B | 11,65B |
| Current Liabilities | 6,81B | 6,80B | 8,27B | 8,39B | 8,14B |